Non Us — Total revenues
Geographic · Total revenuesAmgen Non Us — Total revenues remained flat by 0.0% to $2.58B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.1%, from $2.39B to $2.58B. Over 2 years (FY 2023 to FY 2025), Non Us — Total revenues shows an upward trend with a 11.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase indicates successful international market expansion or higher demand for products in global markets, while a decrease may signal competitive pressure or regulatory hurdles abroad.
Detailed definition
This metric represents the total gross revenue generated by the company from operations outside of its primary domestic...
Peer comparison
Comparable to 'International Revenue' or 'Non-US Revenue' reported by other multinational pharmaceutical and biotechnology firms.
amgn_segment_row_total_revenuesHistorical Data
| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $8.38B | $9.56B | $10.33B |
| YoY Change | — | +14.0% | +8.1% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's non us — total revenues?
- Amgen (AMGN) reported non us — total revenues of $2.58B in Q4 2025.
- How has Amgen's non us — total revenues changed year-over-year?
- Amgen's non us — total revenues increased by 8.1% year-over-year, from $2.39B to $2.58B.
- What is the long-term trend for Amgen's non us — total revenues?
- Over 2 years (2023 to 2025), Amgen's non us — total revenues has grown at a 11.0% compound annual growth rate (CAGR), from $8.38B to $10.33B.
- What does non us — total revenues mean?
- The total sales revenue generated by the company from all geographic regions outside its home country.